Public procurement notice: Contract Award Notice
Published: 2020-05-11
Buyer: Healthcare Quality Improvement Partnership (HQIP)
Country: UK
Contract type: Services
Procedure: Open procedure
CPV classification: 85100000: Health services | 85121200: Specialist medical services | 85140000: Miscellaneous health services | 85148000
Estimated value: 2388765 GBP
Award criteria: The most economic tender

Technical requirements: HQIP manage the Medical and Surgical Clinical Outcome Review Programme on behalf of NHS England, Welsh Government, the Scottish Government, the Northern Ireland Department of Health and the States of Jersey, Guernsey, and the Isle of Man as part of the National Clinical Audit and Patient Output Programme (NCAPOP). The Medical and Surgical Clinical Outcome Review Programme is one of four Clinical Outcome Review Programmes (previously known as confidential enquiries). The work of the programme also complements and contributes to the work of other agencies such as NICE, the Care Quality Commission (CQC), the Royal Colleges and academia that can help improve the quality and safety of healthcare delivery.
The successful bidder will build on the experiences and achievements of the programme since its inception.
Please follow the link to view the specification and to formally express your interest in this contract opportunity. Potential providers must complete the supplier registration form and declaration on the system and submit for approval before they can access the Invitation to Tender (ITT) which is a separate event.
NB: this is a one stage process and the deadline given for the submission of complete tenders is the same as expressions of interest.
The contract is let initially to be delivered for NHS-funded care in England, Wales, Scotland and Northern Ireland for a period of 3 years, at a maximum total budget of up to GBP 2 388 765 excluding VAT and bids exceeding this limit will be rejected. In addition, the States of Jersey and Guernsey, and the Isle of Man, may join the programme at a later date although this is yet to be confirmed. The additional contract value that would be offered to support the participation of the States of Jersey and Guernsey, and the Isle of Man would be GBP 3 080 per annum pro rata excl. VAT. If the States of Jersey and Guernsey, and the Isle of Man joined early in the first year and the whole contract was then extended to the 5 years' total duration, subject to topic prioritisation by the funders, the availability of funding and an assessment by HQIP on the quality of the delivery of the programme, the maximum contract value would be GBP 3 996 000 excl. VAT. The contract is anticipated to start on 1 April 2020.
Extending service coverage to include additional countries and/or devolved nations if they were to buy into the programme and their data needed to be included in the work to be carried out. For the avoidance of doubt, the term devolved nation refers to any body which has had powers relating to health services devolved to it by the Parliament of the United Kingdom, including but not limited to Scotland, Wales, Northern Ireland, Jersey, Guernsey and the Isle of Man.
Additional, associated or enhanced delivery of any aspect of the Medical and Surgical Clinical Outcome Review Programme
Please note, there is no commitment by the Authority at this stage to include any of these. Taking this aspirational intent into account as well as the possibility that a contract extension may be offered for an additional two years, the potential ceiling value is GBP 7 000 000 excluding VAT.
N.B. Bidders should submit their schedule of offer based on ‘core’ delivery for the initial 3 years only. The maximum budget ‘core’ value is GBP 2 388 765 excluding VAT. This excludes the aspirational intent elements listed above.


Winner: National Confidential Enquiry into Patient Outcome and Death (NCEPOD)
Award value: 2388765
Number of bids: 1